Kurz titanium ossicular prostheses offer high biocompatibility an

Kurz titanium ossicular prostheses offer high biocompatibility and high stability with low complication rates in pediatric ossicular reconstruction. (C) 2010 Elsevier Ireland Ltd. All rights reserved.”
“Background: Patients with traumatic brain

injury (TBI) and traumatic intracranial hemorrhage are frequently admitted to the intensive care unit (ICU) but never require critical care interventions. Improved ICU triage in this patient population can improve resource utilization and decrease health care costs. We sought to identify a low-risk group of patients with TBI who do not require admission to an ICU.

Methods: This is a retrospective cohort study of adult patients with TBI and traumatic intracranial hemorrhage. The need for ICU admission check details was defined as the presence of a critical care intervention. Patients were considered low risk if there was no critical care intervention before hospital admission. Measured outcomes included delayed critical care interventions at 48 hours and during hospitalization, mortality, and emergency surgery.

Results: A total of 187 of 320 patients were considered low risk. In the low-risk group,

two patients (1.1%; 95% confidence interval [CI], 0.1-3.8) had a delayed critical care intervention within 48 hours of admission and four patients (2.1%; 95% CI, 0.6-5.4) after 48 hours of admission. Two patients (1.1%; 95% CI, www.selleckchem.com/products/ly2606368.html 0-3.8) in the low-risk group died. No patients in the low-risk group required neurosurgical intervention.

Conclusion: Patients with TBI without a critical care intervention before admission are at low risk for requiring future critical

care interventions. Future studies are required to validate if this low-risk criteria can serve as a safe, cost-effective triage tool for ICU admission.”
“Microencapsulation is a process by which tiny parcels of an active ingredient are packaged within a second material for the purpose of shielding the active ingredient from the surrounding environment. This study aims to determine the ability of the microencapsulation technique to improve the viability of Trichoderma harzianum UPM40 originally isolated from healthy groundnut roots as effective biological control Linsitinib agents (BCAs). Alginate was used as the carrier for controlled release, and montmorillonite clay (MMT) served as the filler. The encapsulated Ca-alginate-MMT beads were characterised using Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA) and scanning electron microscopy (SEM). The FTIR results showed the interaction between the functional groups of alginate and MMT in the Ca-alginate-MMT beads. Peaks at 1595, 1420 and 1020 cm(-1) characterised alginate, and peaks at 1028 and 453 cm(-1) characterised MMT; both sets of peaks appeared in the Ca-alginate-MMT FTIR spectrum. The TGA analysis showed an improvement in the thermal stability of the Ca-alginate-MMT beads compared with the alginate beads alone.

Comments are closed.